Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease colitis
Phenotype C0021831|bowel disease
Sentences 49
PubMedID- 23469045 Inflammatory bowel disease (ibd) comprised of ulcerative colitis (uc) and crohn’s disease (cd) is a chronic inflammatory disorder of the intestinal tract characterized by genetic, immune and environmental factors contributing to its pathogenesis [1], [2].
PubMedID- 22201968 Inflammatory bowel disease (ibd) is comprised of both ulcerative colitis (uc) and crohn's disease (cd) and is a chronic inflammatory disorder that results from a dysregulated immune response in genetically susceptible individuals.
PubMedID- 24348149 Inflammatory bowel disease mainly consisting of ulcerative colitis and crohn's disease has been rising gradually during the last two decades in china.
PubMedID- 23630417 Dysregulation of the mucosal immune system is thought to be the cause of inflammatory bowel diseases (ibd), with ulcerative colitis (uc) and crohn’s disease (cd) as the two major forms.
PubMedID- 23735465 The most common autoimmune diseases include inflammatory bowel disease (consisting of ulcerative colitis and crohn’s disease), rheumatoid arthritis, celiac disease, multiple sclerosis, systemic sclerosis, systemic lupus, type 1 diabetes, and two types of thyroid disease (grave’s disease and hashimoto’s thyroiditis) (cooper et al.
PubMedID- 26090239 In one study, among 213 consecutive patients treated for proven native valve endocarditis, six (2.8%) had inflammatory bowel diseases (three with ulcerative colitis and three with cohn's disease) [8].
PubMedID- 21723221 Background & aims: inflammatory bowel disease increases the risks of colon cancer and colitis-associated cancer (cac).
PubMedID- 24765512 Toxic megacolon (tm) is an infrequent but a potentially life-threatening complication of many colitis.1 primarily associated with inflammatory bowel disease (ibd), tm is also a documented complication of severe infectious, ischemic and metabolic affections of the colon.2 the incidence of tm in crohn’s colitis ranges from 1% to 5%.3 tm is characterized by total or segmental non-obstructive colonic distension of at least 6 cm, associated with systemic toxicity.4 the diagnosis of tm is based on criteria proposed by jalan et al.5 because of the associated high morbidity and mortality, early recognition and management of tm is of paramount importance.
PubMedID- 21321790 Background and purpose: inflammatory bowel disease (ibd) consists of ulcerative colitis (uc) and crohn's disease (cd), which are complex genetic disorders resulting from the interplay between several genetic and environmental risk factors.
PubMedID- 24693269 Inflammatory bowel disease patients with long-standing colitis have an increased risk of colorectal cancer.
PubMedID- 23929268 In comparison to inflammatory bowel disease, patients with lymphocytic/collagenous colitis showed significantly lower numbers of igg4-positive plasma cells (p=0.0001).
PubMedID- 22179924 Background: t cells critically regulate inflammatory bowel disease (ibd), with t-cell-dependent experimental colitis models gaining favor in identifying potential pathogenic mechanisms; yet limited understanding of specific pathogenic molecules or pathways still exists.
PubMedID- 21647408 Inflammatory bowel disease (ibd) comprising of ulcerative colitis (uc) and crohn's disease (cd) is an idiopathic disease characterized by chronic inflammation of the gut.
PubMedID- 20190722 Aim: this was a retrospective survey of 88 inflammatory bowel disease patients (43 with ulcerative colitis, 38 with crohn's disease, 7 with indeterminate colitis) who were visited between january 2008 and june 2009 at a newly established out-patient service at a primary care hospital in turin.
PubMedID- 22833299 Inflammatory bowel disease (ibd) comprising of ulcerative colitis (uc) and crohn's disease (cd) is a major ailment affecting the small and large bowel.
PubMedID- 24813533 Objectives: allergic colitis shows overlap with classic inflammatory bowel disease (ibd).
PubMedID- 23226271 Inflammatory bowel diseases (ibd), with ulcerative colitis (uc) and crohn’s disease (cd) as major entities, are chronic inflammatory disorders of the gastrointestinal tract, affecting an estimated 3.6 million people in europe and the us [1].
PubMedID- 22988345 Inflammatory bowel diseases (ibds), comprised of ulcerative colitis and crohn's disease, are chronic, relapsing-remitting inflammatory diseases of unknown etiology.
PubMedID- 25944127 Introduction: inflammatory bowel disease (ibd) consists of crohn's disease, ulcerative colitis and an unspecific ibd.
PubMedID- 21460390 Results were compared with those recorded in patients with inflammatory bowel disease (ibd) of the colon (ulcerative colitis (uc) or crohn's colitis).
PubMedID- 25553076 Inflammatory bowel disease (ibd), comprised of ulcerative colitis and crohn's disease, is believed to develop as a result of a deregulated inflammatory response to environmental factors in genetically susceptible individuals.
PubMedID- 23649377 Background: inflammatory bowel disease (ibd) consists of ulcerative colitis (uc) and crohn's disease (cd).
PubMedID- 20505143 Ig-free light chains play a crucial role in murine mast cell-dependent colitis and are associated with human inflammatory bowel diseases.
PubMedID- 22941697 The inflammatory bowel diseases (ibds), consisting of ulcerative colitis (uc) and crohn's disease (cd), are characterized by idiopathic, chronic inflammation of the gastrointestinal tract.
PubMedID- 26133362 A young male, with a family history of inflammatory bowel disease, was diagnosed with ulcerative colitis at the age of 20.
PubMedID- 23037465 Most cases of cytomegalovirus (cmv) colitis in patients with inflammatory bowel disease (ibd) occur in those treated with immunosuppressants and/or corticosteroids.
PubMedID- 21987618 Importantly, tolerogenic dcs act by promoting the differentiation and expansion of treg cells that efficiently modulate gut inflammation, as shown both in pre-clinical models of colitis and in patients with inflammatory bowel disease (ibd).
PubMedID- 19924442 996-a allele frequency is also increased in inflammatory bowel disease (ibd): 22% of ulcerative colitis- and 50% of crohn's disease-patients were heterozygous carriers of 996-a (p = 0.052 for cu and p < 0.0001 for mc vs controls).
PubMedID- 19437119 Inflammatory bowel disease (ibd) consists of ulcerative colitis and crohn's disease, both of which are associated with increased colorectal cancer risk.
PubMedID- 25825436 Importantly, infusion of sbm-dcs could alleviate colitis in mice with inflammatory bowel disease by inhibiting lymphocyte proliferation and increasing the numbers of cd4(+)cd25(+) regulatory t cells.
PubMedID- 25685754 Inflammatory bowel disease (ibd), of which ulcerative colitis (uc) and crohn’s disease (cd) are the two prevailing entities, constitutes an important global public health problem with increasing incidence (1).
PubMedID- 21897820 Inflammatory bowel disease (ibd; comprised of ulcerative colitis and crohn’s disease) and microscopic colitis (lymphocytic colitis and collagenous colitis) are two major inflammatory conditions in the colon.
PubMedID- 21707991 An upper and lower gastrointestinal endoscopy and biopsy revealed the presence of an extensive yet non-classical colitis in keeping with unclassified inflammatory bowel disease.
PubMedID- 21669488 Inflammatory bowel disease (ibd) patients diagnosed with ulcerative colitis and irritable bowel syndrome patients without inflammation, serving as controls, were therefore recruited.
PubMedID- 20568970 Cytomegalovirus colitis in patients without inflammatory bowel disease: a single center study.
PubMedID- 23692793 Autoimmunity in inflammatory bowel disease: a case of ulcerative colitis with diabetes mellitus, autoimmune hepatitis and autoimmune hypothyroidism.
PubMedID- 20517857 Background: arterial and venous thrombosis are well recognized systemic complications of inflammatory bowel disease predominantly in patients with crohn's colitis and in those with ulcerative colitis (uc).
PubMedID- 22211319 Inflammatory bowel disease (ibd) consists mainly of ulcerative colitis (uc) and crohn disease (cd).
PubMedID- 21197596 Upregulation of 11β-hsd1 is documented in colonic mucosa in experimental colitis [78] and in patients with inflammatory bowel disease [79].
PubMedID- 25812483 Background: inflammatory bowel diseases (ibd), comprised of ulcerative colitis and crohn's disease, are chronic disorders characterized by worsening of symptoms followed by symptom-free periods.
PubMedID- 21122506 Most cases of cytomegalovirus (cmv) colitis that develop in patients with inflammatory bowel disease (ibd) are caused by reactivation of a latent virus.
PubMedID- 21744425 Background: inflammatory bowel diseases (ibds), consisting of ulcerative colitis (uc) and crohn's disease (cd), are complex disorders with multiple genes contributing to disease pathogenesis.
PubMedID- 20186307 The inflammatory bowel diseases, consisting of crohn's disease, ulcerative colitis and indeterminate colitis, are distinguished by idiopathic and chronic inflammation of the digestive tract.
PubMedID- 21615760 Background: surveillance colonoscopy is recommended for inflammatory bowel disease (ibd) patients with longstanding extensive colitis (lec).
PubMedID- 23406209 Inflammatory bowel diseases (ibds), consisting of ulcerative colitis (uc) and crohn's disease (cd), are complex disorders with multiple genes contributing to disease pathogenesis.
PubMedID- 24520376 It has been suggested that prolonged inflammatory bowel diseases (ibd) may lead to colitis-associated carcinogenesis (cac).
PubMedID- 24390063 We investigated il-10 production in b cells from patients with inflammatory bowel diseases and immunoregulatory functions of bregs in experimental colitis mouse models.
PubMedID- 25379461 Inflammatory bowel diseases (ibds), consisting mainly of ulcerative colitis (uc) and crohn's disease (cd), are important immune-mediated diseases of the gastrointestinal tract.
PubMedID- 25501329 Inflammatory bowel diseases (ibd) comprises of ulcerative colitis (uc) and cohn's disease (cd) as two main idiopathic pathologies resulting in immunologically mediated chronic inflammatory conditions.

Page: 1